| Literature DB >> 20438656 |
Dong-Chul Kim1, Xiaoyu Wang, Chin-Rang Yang, Jean Gao.
Abstract
BACKGROUND: Biological networks offer us a new way to investigate the interactions among different components and address the biological system as a whole. In this paper, a reverse-phase protein microarray (RPPM) is used for the quantitative measurement of proteomic responses.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20438656 PMCID: PMC2863068 DOI: 10.1186/1471-2105-11-S3-S9
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Figure 1Structures with three nodes and two edges
Figure 2Pseudo code for suggested algorithm
Figure 3ASIA and CAR DIAGNOSIS2 networks. ASIA network has 8 nodes and 8 edges (A), and CAR DIAGNOSIS2 network has 18 nodes and 20 edges (B).
Figure 4ALARM network. ALARM network has 37 nodes and 46 edges.
Result for the Asia network
| Method | ME | WOE | WE |
|---|---|---|---|
| Our Method | 0.1 | n/a | 0 |
| Hill-Climbing | 2.2 | 0.8 | 4.8 |
| K2 | 1 | 3.45 | 4.8 |
Result for the Car Diagnosis2 network
| Method | ME | WOE | WE |
|---|---|---|---|
| Our Method | 2 | n/a | 0.8 |
| Hill-Climbing | 2.35 | 5.9 | 8.4 |
| K2 | 1.4 | 9.4 | 16.3 |
Result for the Alarm network
| Method | ME | WOE | WE |
|---|---|---|---|
| Our Method | 6.05 | n/a | 3.85 |
| Hill-Climbing | 1.55 | 9.75 | 9.4 |
| K2 | 2.05 | 22.5 | 53.75 |
Result for Trustworthy Network
| Network | NETN | CETN | ACCURACY |
|---|---|---|---|
| ASIA | 4 | 4 | 100% |
| CAR DIAGNOSIS2 | 13.8 | 13 | 94% |
| ALARM | 29.7 | 26.8 | 90% |
67 antibodies used in the reverse-phase protein array for ATM radiation study
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| mTOR | b-catenin | Chk1 | E-Cad | MDM2 | p38 | p-p38 | pChk2 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| pATM | Rb | pRb | Raf-1 | p-Src | PTEN | STAT3 | Caspase8 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| IGF1-R | IRS-1 | GSK3ab | pGSK3ab | pMDM2 | pSTAT3 | AKT | pAKT |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 |
| Caspase3 | DNAPK | pDNAPK | EGFR | pEGFR | NFkBp65 | pNFkB | NQO1 |
| 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 |
| p21 | p27 | p-PTEN | pRaf1 | Bcl-2 | pBcl-2 | Caspase9 | cdk4 |
| 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 |
| pErk | lkBa | plkBa | JNK | Klotho | p16 | p53 | p-p53 |
| 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
| Smad3 | Src | Vimentin | sClu | ATM | Chk2 | Erk | HSP27 |
| 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 |
| IGFBP | pChk1 | pDNAPK | gH2AX | pIGF1-R(y1158.62.63) | pIGF1-R(y1162.63) | pIRS(Y896) | pIRS(Y1179) |
| 64 | 65 | 66 | |||||
| pJNK | p-mTOR | pSmad3 |
Figure 5Signal networks under the dosages of 4cGy (A), 10cGy (B), and 50cGy (C).
Figure 6Signal networks under the dosages of 1Gy (A) and 5Gy (B).